Terns Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TERN and other ETFs, options, and stocks.About TERN
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program.
TERN Key Statistics
Stock Snapshot
The current Terns Pharmaceuticals(TERN) stock price is $46.18, with a market capitalization of 4.9B. The stock trades at a price-to-earnings (P/E) ratio of -44.64.
As of 2026-03-17, Terns Pharmaceuticals(TERN) stock has fluctuated between $45.77 and $47.98. The current price stands at $46.18, placing the stock +0.9% above today's low and -3.8% off the high.
Terns Pharmaceuticals(TERN) shares are trading with a volume of 2.2M, against a daily average of 2.17M.
In the last year, Terns Pharmaceuticals(TERN) shares hit a 52-week high of $48.26 and a 52-week low of $1.87.
In the last year, Terns Pharmaceuticals(TERN) shares hit a 52-week high of $48.26 and a 52-week low of $1.87.
Analyst ratings
100%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.